SEC Form 4 · accession 0001127602-18-036008
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Dec 10, 2018
Accepted (ET)
Dec 12, 2018 · 12:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2018 | S | 200 | $126.62 | D | 302,985 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.63 | D | 302,885 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.64 | D | 302,685 | D | |
| Common Stock | Dec 10, 2018 | S | 50 | $126.66 | D | 302,635 | D | |
| Common Stock | Dec 10, 2018 | S | 108 | $126.665 | D | 302,527 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.67 | D | 302,327 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.685 | D | 302,227 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.69 | D | 302,127 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.70 | D | 302,027 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.71 | D | 301,827 | D | |
| Common Stock | Dec 10, 2018 | S | 8 | $126.715 | D | 301,819 | D | |
| Common Stock | Dec 10, 2018 | S | 301 | $126.73 | D | 301,518 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.74 | D | 301,318 | D | |
| Common Stock | Dec 10, 2018 | S | 134 | $126.75 | D | 301,184 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.755 | D | 301,084 | D | |
| Common Stock | Dec 10, 2018 | S | 600 | $126.76 | D | 300,484 | D | |
| Common Stock | Dec 10, 2018 | S | 72 | $126.765 | D | 300,412 | D | |
| Common Stock | Dec 10, 2018 | S | 400 | $126.77 | D | 300,012 | D | |
| Common Stock | Dec 10, 2018 | S | 31 | $126.78 | D | 299,981 | D | |
| Common Stock | Dec 10, 2018 | S | 252 | $126.785 | D | 299,729 | D | |
| Common Stock | Dec 10, 2018 | S | 1 | $126.795 | D | 299,728 | D | |
| Common Stock | Dec 10, 2018 | S | 324 | $126.80 | D | 299,404 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.81 | D | 299,304 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.82 | D | 299,204 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.